105
Participants
Start Date
September 30, 2024
Primary Completion Date
December 3, 2026
Study Completion Date
February 18, 2027
E2814
E2814 IV infusion.
Lecanemab
Lecanemab SC injection.
Placebo
Placebo IV infusion.
Abington Neurological Associates Ltd, Abington
National Clinical Research-Richmond, Inc, Richmond
Columbus Memory Center, PC, Columbus
Progressive Medical Research, Port Orange
Charter Research, Lady Lake
Advanced Clinical Research Network, Miami
Alzheimer's Research and Treatment Center, Wellington
Axiom Brain Health, Tampa
Bradenton Research Center, Bradenton
Renstar Medical Research, Ocala
K2 Medical Research, Clermont
Alzheimer's Research and Treatment Center, Stuart
Neurology Clinical, P.C., Cordova
Memory Center/Hattiesburg Clinic, Hattiesburg
Washington University School of Medicine, St Louis
Banner Sun Health Research Institute, Sun City
Tokyo Metropolitan Institute for Geriatrics and Gerontology, Tokyo
Nippon Medical School Hospital, Kanagawa
Yamagata Tokushukai Hospital, Yamagata
Yale University School of Medicine, New Haven
Kerwin Medical Center, Dallas
National Center for Geriatrics and Gerontology, Ōbu
National Hospital Organization Hiroshima-Nishi Medical Center, Ōtake
Keimei Memorial Hospital, Higashimorokatagun
Rijikai Medical Corporation Katayama Medical Clinic, Kurashiki
Osaka Metropolitan University Hospital, Osaka
Tokyo Medical University Hospital, Tokyo
Keio University Hospital, Tokyo
Eisai Inc.
INDUSTRY